KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Gross Margin (2016 - 2026)

Medtronic (MDT) has disclosed Gross Margin for 13 consecutive years, with 63.83% as the latest value for Q1 2026.

  • Quarterly Gross Margin fell 265.0% to 63.83% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 64.86% through Jan 2026, down 41.0% year-over-year, with the annual reading at 65.32% for FY2025, 3.0% down from the prior year.
  • Gross Margin hit 63.83% in Q1 2026 for Medtronic, down from 65.84% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 68.32% in Q1 2022 to a low of 63.83% in Q1 2026.
  • Historically, Gross Margin has averaged 65.68% across 5 years, with a median of 65.42% in 2023.
  • Biggest five-year swings in Gross Margin: surged 203bps in 2022 and later crashed -312bps in 2023.
  • Year by year, Gross Margin stood at 66.58% in 2022, then decreased by -2bps to 65.42% in 2023, then dropped by -1bps to 64.94% in 2024, then grew by 1bps to 65.84% in 2025, then dropped by -3bps to 63.83% in 2026.
  • Business Quant data shows Gross Margin for MDT at 63.83% in Q1 2026, 65.84% in Q4 2025, and 65.02% in Q3 2025.